Table 4. Sensitivity analysis of Hazard ratio for incident DM in both groups after excluding new DM cases within 3 or 6 months after enrollments.
Alendronate exposure | Incident DM, n (%) | Adjusted* hazard ratio (95% CI) | P value | |
---|---|---|---|---|
Excluding DM < = 3 months | Exposed group (n = 1000) | 185(18.50) | 1.00 | 0.0381 |
Non-exposed group (n = 2974) | 631(21.22) | 1.19(1.01–1.40) | ||
Excluding DM < = 6 month | Exposed group (n = 988) | 173(17.51) | 1.00 | 0.0470 |
Non-exposed group (n = 2932) | 589(20.09) | 1.19(1.00–1.41) |
*Adjust for Age, Gender, dyslipidemia and HTN